Montelukast Tablet, Film Coated
Product Images NDC 72865-175

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Montelukast (NDC 72865-175). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Xlcare Pharmaceuticals Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1.jpg (Figure1)

Chemical structure diagram of Montelukast sodium, showing its molecular composition including chlorine, sulfur, and sodium atoms as part of the structure.*

FDA Label Image

Figure2.jpg (Figure2)

A line graph comparing mean percent change from baseline over 15 weeks of treatment between placebo and Montelukast Sodium. The x-axis represents weeks of treatment, and the y-axis shows the mean percent change from baseline. The graph includes a washout period after 12 weeks, shown with a dashed line for Montelukast Sodium.*

FDA Label Image

Montesodtab10mg30scount (Montesodtab10mg30scount)

Montelukast Sodium Tablets, USP 10 mg film-coated tablets label by XLCare Pharmaceuticals Inc. The label includes product strength, quantity of 30 tablets, and usage instructions indicating the medication is for adults 15 years and older. It lists manufacturing details for XLCare Pharmaceuticals and Evaric Pharmaceuticals, with storage instructions and a U.S. contact number.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.